3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide

C139H265F3N24O19 — CID 160931062

IUPAC3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
SMILESCC(C)CC(=O)NC1(CN2CCCC2)CCN(C(C)C)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(C)(C)O)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(F)(F)F)CC1.CC(O)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CCC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CCCC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC(C)(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC1(C(=O)NC2(CN3CCOCC3)CCN(C(C)C)CC2)CC1
InChIInChI=1S/C19H37N3O3.C18H33N3O3.C18H35N3O3.C18H35N3O.C17H33N3O3.C17H33N3O2.C16H28F3N3O2.C16H31N3O2/c1-16(2)22-8-6-19(7-9-22,15-21-10-12-25-13-11-21)20-17(23)14-18(3,4)24-5;1-15(2)21-8-6-17(7-9-21,14-20-10-12-24-13-11-20)19-16(22)18(23-3)4-5-18;1-15(2)21-7-5-18(6-8-21,14-20-9-11-24-12-10-20)19-16(22)13-17(3,4)23;1-15(2)13-17(22)19-18(14-20-9-5-6-10-20)7-11-21(12-8-18)16(3)4;1-14(2)20-6-4-17(5-7-20,18-16(22)12-15(3)21)13-19-8-10-23-11-9-19;1-4-5-16(21)18-17(14-19-10-12-22-13-11-19)6-8-20(9-7-17)15(2)3;1-13(2)22-5-3-15(4-6-22,12-21-7-9-24-10-8-21)20-14(23)11-16(17,18)19;1-4-15(20)17-16(13-18-9-11-21-12-10-18)5-7-19(8-6-16)14(2)3/h16H,6-15H2,1-5H3,(H,20,23);15H,4-14H2,1-3H3,(H,19,22);15,23H,5-14H2,1-4H3,(H,19,22);15-16H,5-14H2,1-4H3,(H,19,22);14-15,21H,4-13H2,1-3H3,(H,18,22);15H,4-14H2,1-3H3,(H,18,21);13H,3-12H2,1-2H3,(H,20,23);14H,4-13H2,1-3H3,(H,17,20)
InChIKeySTGSFNAKHCWJNE-UHFFFAOYSA-N
MW2633.79 g/mol
LogP10.32
Rot. Bonds47

About 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide

3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide (PubChem CID 160931062) has the molecular formula C139H265F3N24O19 and a molecular weight of 2633.79 g/mol. Its IUPAC name is 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide.

Molecular Properties

Compound Name3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
PubChem CID160931062
Molecular FormulaC139H265F3N24O19
Molecular Weight2633.79 g/mol
Exact Mass2632.05
IUPAC Name3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
SMILESCC(C)CC(=O)NC1(CN2CCCC2)CCN(C(C)C)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(C)(C)O)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(F)(F)F)CC1.CC(O)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CCC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CCCC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC(C)(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC1(C(=O)NC2(CN3CCOCC3)CCN(C(C)C)CC2)CC1
InChIInChI=1S/C19H37N3O3.C18H33N3O3.C18H35N3O3.C18H35N3O.C17H33N3O3.C17H33N3O2.C16H28F3N3O2.C16H31N3O2/c1-16(2)22-8-6-19(7-9-22,15-21-10-12-25-13-11-21)20-17(23)14-18(3,4)24-5;1-15(2)21-8-6-17(7-9-21,14-20-10-12-24-13-11-20)19-16(22)18(23-3)4-5-18;1-15(2)21-7-5-18(6-8-21,14-20-9-11-24-12-10-20)19-16(22)13-17(3,4)23;1-15(2)13-17(22)19-18(14-20-9-5-6-10-20)7-11-21(12-8-18)16(3)4;1-14(2)20-6-4-17(5-7-20,18-16(22)12-15(3)21)13-19-8-10-23-11-9-19;1-4-5-16(21)18-17(14-19-10-12-22-13-11-19)6-8-20(9-7-17)15(2)3;1-13(2)22-5-3-15(4-6-22,12-21-7-9-24-10-8-21)20-14(23)11-16(17,18)19;1-4-15(20)17-16(13-18-9-11-21-12-10-18)5-7-19(8-6-16)14(2)3/h16H,6-15H2,1-5H3,(H,20,23);15H,4-14H2,1-3H3,(H,19,22);15,23H,5-14H2,1-4H3,(H,19,22);15-16H,5-14H2,1-4H3,(H,19,22);14-15,21H,4-13H2,1-3H3,(H,18,22);15H,4-14H2,1-3H3,(H,18,21);13H,3-12H2,1-2H3,(H,20,23);14H,4-13H2,1-3H3,(H,17,20)
InChIKeySTGSFNAKHCWJNE-UHFFFAOYSA-N
XLogP10.32
TPSA408.17 Ų
H-Bond Donors10
H-Bond Acceptors35
Rotatable Bonds47
Heavy Atoms185
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002633.79
LogP ≤ 510.32
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1035

Analyze 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

tert-butyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)acetamide;2-hydroxy-3-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)butanamide;3-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)butanamide;2-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)propanamide;N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclopropanecarboxamide;N-(3-methyl-1-propan-2-ylpyrrolidin-3-yl)cyclopropanecarboxamide;2-methylpropyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;propan-2-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3,3,3-trifluoro-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)propanamide
CID 157198358
tert-butyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)acetamide;2,3-dimethyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)butanamide;2-hydroxy-3-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)butanamide;2-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)propanamide;N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclopropanecarboxamide;N-(3-methyl-1-propan-2-ylpyrrolidin-3-yl)cyclopropanecarboxamide;2-methylpropyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;propan-2-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3,3,3-trifluoro-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)propanamide
CID 158218800
tert-butyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)acetamide;2-hydroxy-3-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)butanamide;3-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)butanamide;2-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)propanamide;N-(3-methyl-1-propan-2-ylpyrrolidin-3-yl)cyclopropanecarboxamide;2-methylpropyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;propan-2-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3,3,3-trifluoro-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)propanamide
CID 160225104
3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
CID 160721733
tert-butyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)acetamide;2-hydroxy-3-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)butanamide;3-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)butanamide;2-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)propanamide;N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclopropanecarboxamide;N-(4-methyl-1-propan-2-ylpiperidin-4-yl)propanamide;N-(3-methyl-1-propan-2-ylpyrrolidin-3-yl)cyclopropanecarboxamide;2-methylpropyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;propan-2-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3,3,3-trifluoro-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)propanamide
CID 161918694
2,2-dimethylpropyl N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
CID 161989988
N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2-methylpropanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
CID 161993679
2,2-dimethylpropyl N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
CID 157551330
2,2-dimethylpropyl N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methylpropyl N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;propan-2-yl N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]carbamate
CID 160067173

Frequently Asked Questions

What is the IUPAC name of 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide?
The IUPAC name of 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide (CID 160931062) is 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide.
What is the SMILES notation for 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide?
The canonical SMILES for 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide is CC(C)CC(=O)NC1(CN2CCCC2)CCN(C(C)C)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(C)(C)O)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(F)(F)F)CC1.CC(O)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CCC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CCCC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC(C)(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC1(C(=O)NC2(CN3CCOCC3)CCN(C(C)C)CC2)CC1.
What is the InChIKey of 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide?
The InChIKey is STGSFNAKHCWJNE-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H37N3O3.C18H33N3O3.C18H35N3O3.C18H35N3O.C17H33N3O3.C17H33N3O2.C16H28F3N3O2.C16H31N3O2/c1-16(2)22-8-6-19(7-9-22,15-21-10-12-25-13-11-21)20-17(23)14-18(3,4)24-5;1-15(2)21-8-6-17(7-9-21,14-20-10-12-24-13-11-20)19-16(22)18(23-3)4-5-18;1-15(2)21-7-5-18(6-8-21,14-20-9-11-24-12-10-20)19-16(22)13-17(3,4)23;1-15(2)13-17(22)19-18(14-20-9-5-6-10-20)7-11-21(12-8-18)16(3)4;1-14(2)20-6-4-17(5-7-20,18-16(22)12-15(3)21)13-19-8-10-23-11-9-19;1-4-5-16(21)18-17(14-19-10-12-22-13-11-19)6-8-20(9-7-17)15(2)3;1-13(2)22-5-3-15(4-6-22,12-21-7-9-24-10-8-21)20-14(23)11-16(17,18)19;1-4-15(20)17-16(13-18-9-11-21-12-10-18)5-7-19(8-6-16)14(2)3/h16H,6-15H2,1-5H3,(H,20,23);15H,4-14H2,1-3H3,(H,19,22);15,23H,5-14H2,1-4H3,(H,19,22);15-16H,5-14H2,1-4H3,(H,19,22);14-15,21H,4-13H2,1-3H3,(H,18,22);15H,4-14H2,1-3H3,(H,18,21);13H,3-12H2,1-2H3,(H,20,23);14H,4-13H2,1-3H3,(H,17,20).
What are the key properties of 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide?
3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide has a molecular weight of 2633.79 g/mol, XLogP of 10.32, 47 rotatable bonds, 10 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;3-methyl-N-[1-propan-2-yl-4-(pyrrolidin-1-ylmethyl)piperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide is sourced from PubChem (CID 160931062), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).